Variation in Routine Use of a 60 to 63 Gy Intermediate Dose Clinical Target Volume With Primary Radiation therapy for Mucosal Squamous Cell Carcinoma of the Head and Neck

Freedman, L., Galloway, T., Hu, K., & Mierzwa, M. (2022). Variation in Routine Use of a 60 to 63 Gy Intermediate Dose Clinical Target Volume With Primary Radiation therapy for Mucosal Squamous Cell Carcinoma of the Head and Neck. Practical Radiation Oncology, 12(5), e393–e396. https://doi.org/10.1016/j.prro.2022.03.010